Position in PODD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,202,270
-$1,673,626 QoQ
Shares Held
10,495
-23.0% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PODD Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Verition Fund Management LLC holds $151,156,125 across 17 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PEN |
Penumbra Inc
|
142,309 | $44,934,066 | |
| 2 | EW |
Edwards Lifesciences Corp
|
200,695 | $18,154,869 | |
| 3 | BSX |
Boston Scientific Corp
|
410,164 | $17,505,799 | |
| 4 | TNDM |
Tandem Diabetes Care Inc
|
700,000 | $10,563,000 | |
| 5 | MDT |
Medtronic plc
|
119,489 | $9,347,624 | |
| 6 | AVNS |
Avanos Medical, Inc.
|
320,442 | $7,972,596 | |
| 7 | HAE |
Haemonetics Corp
|
105,508 | $7,913,100 | |
| 8 | IRTC |
iRhythm Holdings, Inc.
|
55,987 | $6,659,653 |
All Filings in PODD
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,202,270 | 10,495 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,875,896 | 13,636 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,200,580 | 13,606 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,493,053 | 39,764 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $17,795,766 | 67,765 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,683,277 | 10,278 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $599,098 | 2,574 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $312,790 | 1,550 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $784,155 | 4,575 | Shares | Sole | 2024-05-14 | |
| 2023-09-30 | $5,419,629 | 33,981 | Shares | Sole | 2023-11-14 | |
| 2021-06-30 | $473,804 | 1,726 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||